Seelos Therapeutics's total assets for Q2 2024 were $2.38M, a decrease of -34.08% from the previous quarter. SEEL total liabilities were $30.51M for the fiscal quarter, a -16.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.